GlassScriptPhysician profile
Kyle N Lipke
NPI 1174719389
$1,314.24
in general payments reported to CMS, 2019-2025
17 companies · $16.03 in 2025
The $16.03 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $52.60 · 2022: $299 · 2023: $404 · 2024: $543 · 2025: $16.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $962.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $270.99 | 2022-2025 | |
| Glaxosmithkline, LLC. | $149.73 | 2022-2024 | Trelegy Ellipta, Bexsero, Shingrix |
| Novo Nordisk INC | $143.27 | 2022-2024 | Ozempic, Rybelsus |
| Sumitomo Pharma America, INC. | $132.18 | 2023-2024 | Gemtesa |
| Abbvie INC. | $105.62 | 2023-2024 | |
| Lilly USA, LLC | $76.82 | 2022-2024 | Jardiance, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.31 | 2021-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $63.05 | 2021-2024 | Vaxelis, Gardasil 9, Vaxneuvance |
| Astrazeneca Pharmaceuticals LP | $57.53 | 2022-2024 | Airsupra |
| Exact Sciences Corporation | $55.05 | 2023-2024 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $48.08 | 2022 | |
| Abbott Laboratories | $37.23 | 2024 | Freestyle Libre 3 |
| Amgen INC. | $33.82 | 2023-2024 | Repatha, Otezla |
| Sunovion Pharmaceuticals INC. | $24.40 | 2022 | |
| Sanofi Pasteur INC. | $19.87 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $14.54 | 2023 | Wavewriter Alpha Prime 16 |
| Dexcom, INC. | $13.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Lipke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.